ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/12/2025
Back to search
Official data from USPTO
KIADIS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KIADIS PHARMA
ST13
US500000097095888Class
5, 9, 10, 42
Filing
97095888
Registration
7040075
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
03/12/2025
Trademark type
Word
Nice classes
5, 9, 10, 42
Filing date
10/27/2021
Registration date
05/02/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/02/2023
Last transaction
03/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
26
Owner location
AMSTERDAM, NL
Examiner
BERLIN, JUSTIN
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
KIADIS PHARMA NETHERLANDS B.V.
Kiadis Pharma Intellectual Property B.V.
Representatives
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the treatment of cancer
Class 9
Downloadable electronic publications in the nature of articlespostersnewsletters in the field of healthmedical and health information and reviews of scientific studies
Class 10
Surgicalmedicaldental and veterinary apparatus and instruments for preventing and treating cancerexcluding orthopedic apparatus and instruments
Class 42
Scientific and technological servicesscientific research and design in the field of pharmaceuticals; industrial analysis and industrial research services in the field of pharmaceuticals; providing medical and scientific researchconducting and reporting clinical trials for others; design and development of computer software; all of the foregoing services related to the fight against all forms of cancer
Publications
History of USPTO decisions and trademark events.
16 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/02/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2023
PUBO
PUBLISHED FOR OPPOSITION
02/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/04/2022
GNRT
NON-FINAL ACTION E-MAILED
08/04/2022
CNRT
NON-FINAL ACTION WRITTEN
08/04/2022
DOCK
ASSIGNED TO EXAMINER
08/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2021
NWAP
NEW APPLICATION ENTERED
10/30/2021
Continuous trademark protection
Get notified about every new filing that threatens KIADIS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.